Showing results (1081-1090 of 1,823) with videos related to
Sort By:
Pageof 183
Transplantation and Cellular Therapy|June 21, 2021
Reduction in Late Mortality Among Patients With Multiple Myeloma Treated With Autologous Peripheral Blood Stem Cell Transplantation-A Blood or Marrow Transplant Survivor Study ReportSmith Giri, Yanjun Chen, Jessica Wu, et al.Transplantation and Cellular Therapy|June 21, 2021
The Efficacy and Safety of Chemotherapy-Based Stem Cell Mobilization in Multiple Myeloma Patients Who Are Poor Responders to Induction: The Mayo Clinic ExperienceIuliana Vaxman, Eli Muchtar, Eapen Jacob, et al.Transplantation and Cellular Therapy|June 3, 2021
Comparable Outcomes After Alternative and Matched Sibling Donor Hematopoietic Stem Cell Transplantation and the Role of Molecular Measurable Residual Disease for Acute Myeloid Leukemia in Elderly PatientsByung-Sik Cho, Seung-Ah Yahng, Gi-June Min, et al.Transplantation and Cellular Therapy|June 3, 2021
Donor-Host Lineage-Specific Chimerism Monitoring and Analysis in Pediatric Patients Following Allogeneic Stem Cell Transplantation: Influence of Pretransplantation Variables and Correlation with Post-Transplantation OutcomesGabriela Llaurador, Eileen Nicoletti, Susan E Prockop, et al.Transplantation and Cellular Therapy|November 28, 2022
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant ResearchM L Schoettler, E Carreras, B Cho, et al.Transplantation and Cellular Therapy|December 5, 2022
HLA Factors versus Non-HLA Factors for Haploidentical Donor SelectionRohtesh S Mehta, Kai Cao, Rima M Saliba, et al.Transplantation and Cellular Therapy|June 7, 2022
ASTCT Committee on Practice Guidelines Survey on Evaluation & Management of Diffuse Large B-cell Lymphoma after Failure of Chimeric Antigen Receptor T Cell Therapy (CAR-T) TherapyNausheen Ahmed, Ambuj Kumar, Mohamed A Kharfan-Dabaja, et al.Transplantation and Cellular Therapy|May 11, 2022
Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell TransplantationParastoo B Dahi, Andrew Lin, Michael Scordo, et al.Transplantation and Cellular Therapy|June 29, 2022
Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular TherapyMiguel-Angel Perales, Larry D Anderson, Tania Jain, et al.Transplantation and Cellular Therapy|November 25, 2022
Noninfectious Pulmonary Complications after Hematopoietic Stem Cell TransplantationJohnathan Fraebel, Brian G Engelhardt, Tae Kon KimPageof 183